NSCLC New TKI shows Effectiveness in EGFR-Resistance Mutation

被引：0
|
作者：
Manych, Matthias
机构：
来源：
PNEUMOLOGIE | 2015年 / 69卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：631 / 631
页数：1
相关论文
共 50 条
  • [1] Acquired resistance in NSCLC with EGFR mutation treated with TKI's
    Lueers, A.
    Hallas, C.
    Henke, R. -P
    Falk, M.
    Tiemann, M.
    Griesinger, F.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 6 - 6
  • [2] Activating IDH Mutation as Resistance Mechanism to EGFR TKI in EGFR plus NSCLC
    Chen, S.
    Zhu, H.
    Jin, M.
    Liu, Z.
    Li, J.
    Hong, C.
    Li, T.
    Zhu, X.
    Meng, L.
    Qi, D.
    Zhang, X.
    Ma, T.
    Dong, L.
    Teng, L.
    Li, X.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S681 - S682
  • [3] Retreatment with EGFR-TKI for 541 NSCLC Patients with EGFR Mutation
    Takahashi, K.
    Ito, K.
    Murotani, K.
    Asada, K.
    Okuno, M.
    Kimura, T.
    Kubo, A.
    Suda, T.
    Taniguchi, H.
    Hataji, O.
    Shindo, J.
    Kunii, E.
    Yoshida, T.
    Imaizumi, K.
    Hida, T.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S833 - S833
  • [4] EGFR-TKI FOR EGFR MUTATED NSCLC: NEW EVIDENCE
    Okamoto, I.
    ANNALS OF ONCOLOGY, 2010, 21 : 40 - 40
  • [5] The mutation profile of genes related to primary resistance to EGFR-TKI in early NSCLC.
    Ye, Jiangang
    Zhang, Qi
    Zhang, Xing
    Qin, Huijuan
    Tian, Minqi
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [6] A NOVEL CRM1 INHIBITOR TARGETING FOR NSCLC WITH EGFR-TKI RESISTANCE MUTATION
    Wang, Shuai
    Han, Xiaohong
    Shi, Yuankai
    Wang, Michael
    Zhang, Liang
    Mccauley, Dilara
    Kauffman, Michael Kauffman
    Shacham, Sharon Shacham
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S774 - S774
  • [7] Clinical Features and Tumor Immune Microenvironment Related to Acquired Resistance to EGFR-TKI in NSCLC Patients with EGFR Mutation
    Zhang, P.
    Tu, L.
    Liu, R.
    Xu, X.
    Bao, Z.
    Xu, P.
    Wang, J.
    Li, H.
    Zhou, J.
    Wang, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S402 - S403
  • [8] ACQUIRED RESISTANCE IN NSCLC WITH EGFR MUTATION TREATED WITH TKI'S: SINGLE CENTER EXPERIENCE AND TREATMENT OUTCOME
    Griesinger, Frank
    Halbfass, Volker
    Conradi, Imme
    Hallas, Cora
    Henke, R. P.
    Falk, Markus
    Tiemann, Markus
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S798 - S799
  • [9] Acquired resistance in NSCLC with EGFR mutation treated with TKI's: Single center experience and treatment outcome
    Griesinger, F.
    Halbfass, V
    Conradi, I
    Hallas, C.
    Henke, R-P
    Falk, M.
    Tiemann, M.
    ONKOLOGIE, 2013, 36 : 30 - 31
  • [10] EGFR-TKI resistance in NSCLC patients: mechanisms and strategies
    Lin, Yuxin
    Wang, Xian
    Jin, Hongchuan
    AMERICAN JOURNAL OF CANCER RESEARCH, 2014, 4 (05): : 411 - 435
12345